PortalPublikationenProgression-free survival: does a correlation with survival ...

Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?

Standard

Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? / Becker, Andreas; Eichelberg, Christian; Sun, Maxine.

in: CANCER J, Jahrgang 120, Nr. 1, 01.01.2014, S. 7-10.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Becker, A, Eichelberg, C & Sun, M 2014, 'Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?', CANCER J, Jg. 120, Nr. 1, S. 7-10. https://doi.org/10.1002/cncr.28378

APA

Becker, A., Eichelberg, C., & Sun, M. (2014). Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? CANCER J, 120(1), 7-10. https://doi.org/10.1002/cncr.28378

Vancouver

Becker A, Eichelberg C, Sun M. Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint? CANCER J. 2014 Jan 1;120(1):7-10. https://doi.org/10.1002/cncr.28378

Bibtex

@article{1a365793b4f54891ae38ed69a194a6a3,
title = "Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?",
keywords = "Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Female, Humans, Interferon-alpha, Kidney Neoplasms, Male",
author = "Andreas Becker and Christian Eichelberg and Maxine Sun",
note = "Document Type: Editorial Material",
year = "2014",
month = jan,
day = "1",
doi = "10.1002/cncr.28378",
language = "English",
volume = "120",
pages = "7--10",
journal = "CANCER J",
issn = "1528-9117",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

RIS

TY - JOUR

T1 - Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?

AU - Becker, Andreas

AU - Eichelberg, Christian

AU - Sun, Maxine

N1 - Document Type: Editorial Material

PY - 2014/1/1

Y1 - 2014/1/1

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carcinoma, Renal Cell

KW - Female

KW - Humans

KW - Interferon-alpha

KW - Kidney Neoplasms

KW - Male

U2 - 10.1002/cncr.28378

DO - 10.1002/cncr.28378

M3 - Other (editorial matter etc.)

C2 - 24347382

VL - 120

SP - 7

EP - 10

JO - CANCER J

JF - CANCER J

SN - 1528-9117

IS - 1

ER -